Ranked Nation's 6th Best Hospital
DENVER, Feb. 19 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, announced today that its Wyndgate Technologies(R) division has signed an agreement with NewYork-Presbyterian Hospital (NYP), one of the most comprehensive university hospitals in the world, to license its SafeTrace Tx(R) transfusion management software for implementation at its Weill Cornell Medical Center facility. Terms of the agreement were not disclosed.
NewYork-Presbyterian Hospital performed more than 47,000 surgeries in 2007, creating the critical need for a robust software system to manage transfusions. SafeTrace Tx is designed to support enterprise-wide centralized transfusion services (CTS), which is the management of matching patients to correct blood components across multi-facility institutions. These processes are supported by Wyndgate's patent-approved remote crossmatch function in SafeTrace Tx which helps to prevent excess blood waste by selecting inventory for transfusion from any of their networked facilities. The system also provides comprehensive tracking of orders, specimens, blood products, derivatives and accessories with a complete testing and transfusion history in one consolidated record. These software functions can help to raise the standard of care for patients, improve safety, reduce waste and increase efficiency in the blood bank.
Wm. Scott Dustin, Vice President of Sales and Marketing for Wyndgate Technologies, cites the ability of SafeTrace Tx to function in a multi-hospital setting as one of the key reasons NYP chose Wyndgate's transfusion management software. "It is vital for NewYork-Presbyterian to be able to move patients between facilities depending on the medical discipline required. The advanced functionality in SafeTrace Tx will allow the blood banks to share critical patient information between institutions and help their staff to more efficiently manage orders and blood product inventory."
Thomas F. Marcinek, President and Chief Operating Officer for Wyndgate Technologies, commented, "It is an honor to have been selected by such an outstanding institution. We are very proud that NewYork-Presbyterian/Weill Cornell Medical Center has chosen to join the growing list of prominent university hospitals using Wyndgate's blood management software. NewYork-Presbyterian has a solid reputation as a leader in scientific research, advancing medical knowledge, and extending quality patient care." Mr. Marcinek continued, "Wyndgate appreciates the important role SafeTrace Tx will play in enhancing patient care and safety at NYP by enabling dependable access to critical information. We are committed to developing products which enhance patient safety and continue to be on the cutting edge of blood management technology. We look forward to a long relationship with NewYork-Presbyterian."
About NewYork-Presbyterian Hospital/Weill Cornell Medical Center
Weill Cornell Medical Center is one of two medical centers that comprise NewYork-Presbyterian Hospital, one of the most comprehensive university hospitals in the world. NewYork-Presbyterian Hospital/Weill Cornell Medical Center, together with New York-Presbyterian Hospital/Columbia University Medical Center, have a combined budget of $2.6 billion. With leading specialists in every field of medicine, NYP's high scores earned them a rank of 6th in the nation on the 2007 'U.S. News Honor Roll of America's Best Hospitals'. NewYork-Presbyterian Hospital has earned a reputation as a healthcare leader with its dedicated staff, modern facilities, state-of-the-art technology, commitment to quality care, and role in educating future physicians. This federation of top-level hospitals, specialty institutes, and continuing care centers in New York, New Jersey, and Connecticut delivers a wide range of services to the communities it serves.
About Global Med Technologies, Inc.
Global Med Technologies(R), Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are also being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the Donor Doc(TM) interactive donor health history questionnaire, SafeTrace(R) donor management system, and the SafeTrace Tx(R) advanced transfusion management system, recently patented, provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. Global Med's PeopleMed(R), Inc. subsidiary provides custom software validation, consulting and compliance solutions to hospitals and blood centers. PeopleMed's in-depth knowledge of Wyndgate's products and the blood banking industry results in cost-effective validation services, which leads to more efficient software implementations and upgrades for our customers.
This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
|SOURCE Global Med Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved